Plain-English translation of NCT07237750 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new minimally invasive endoscopic procedure called endoscopic radial compression gastroplasty (ERCG) that reduces stomach volume to help with weight loss. Participants will either receive the ERCG procedure plus a structured lifestyle program of diet counseling and exercise, or receive the lifestyle program alone. Early studies show the procedure can help people lose about 12% of their body weight in 3 months with a good safety profile.
Many people with excess weight try diet and exercise but don't achieve lasting results, yet they aren't eligible for or don't want major weight-loss surgery because it's invasive and expensive. This trial exists to test whether a less invasive endoscopic procedure could offer an effective middle ground for people stuck between lifestyle efforts and traditional surgery.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will be randomly assigned to one of two groups. One group will undergo the endoscopic procedure (done under sedation) followed by a structured program of nutrition counseling, exercise prescription, and behavioral support. The other group will receive the same lifestyle program without the procedure. All participants will have follow-up visits at 1 month, 2 months, 3 months, and 6 months to measure weight loss and monitor health. The trial lasts 6 months from enrollment.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China